NS
Article DetailSEC EDGAR Filings
首页文档检索台
SEC EDGAR Filings

8-K - Neurogene Inc. - 5.02 / 7.01 / 9.01

Filed: 2026-04-20 AccNo: 0001404644-26-000030 Size: 176 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits
查看原文来源主页查看事件簇按来源查看
发布时间04/20 11:32 UTC
首次发现04/20 11:36 UTC
热度107.2
重要度84
情绪-0.02

站内整理正文

优先显示结构化正文；如果正文还未抽出，则回退到摘要。
sec_edgar_index_v1 · 856 字符

Form 8-K - Current report: SEC Accession No. 0001404644-26-000030

Filing Date: 2026-04-20

Accepted: 2026-04-20 07:32:05

Documents: 13

Period of Report: 2026-04-20

Items: Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

Neurogene Inc. (Filer) CIK : 0001404644 (see all company filings) EIN. : 980542593 | Fiscal Year End: 1231 Type: 8-K | Act: 34 | File No.: 001-36327 | Film No.: 26873354 SIC : 2834 Pharmaceutical Preparations (CF Office: 03 Life Sciences)

1 | 8-K | ngne-20260420.htm iXBRL | 8-K

2 | EX-99.1 | ngne_prxccoxbodxfinal.htm | EX-99.1

6 | image_0.jpg | GRAPHIC | 3474

3 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | ngne-20260420.xsd | EX-101.SCH